Injective (INJ) is currently priced at $3.27, reflecting a slight decline of 0.79% over the last 24 hours. The daily price range has been narrow, with a high of $3.35 and a low of $3.26, indicating limited volatility during this period.

Trading volume stands at approximately $44.34 million, representing 13.55% of its market cap, which suggests moderate investor interest. The hourly moving averages show a bearish trend, with short-term SMAs all trading below the current price, signaling potential downward momentum.

The 1-hour RSI is at 41, suggesting that INJ is approaching oversold territory, while the 7-day RSI at 52 indicates a neutral stance in the short-term. Over the past week, INJ has experienced an 8.56% price increase, and its 14-day and 30-day price changes of 16.22% and 11.16% respectively indicate a recovering trend from a longer perspective.

Despite the recent slight decline, the overall price performance over the past month is positive, showing resilience. However, the lack of strong bullish indicators in the short-term moving averages and the relatively low hourly RSI raise concerns about immediate upside potential.

Given the current technical indicators and the recent price performance, the recommendation is to Hold. While there are signs of recovery in longer timeframes, short-term trends suggest caution, as the market may need further consolidation before a clear upward movement is established.